Mesenchymal stem cell therapy shows promise for treating MS, but more research is needed on long-term safety and efficacy, a ...

In a cohort of Black and Hispanic individuals with relapsing MS, baseline comorbidities had no significant effect on the ...

Multiple sclerosis (MS) is a neurological disease that affects about 1 million people in the United States. Your brain contains a type of cell called a neuron, and neurons are coated in a layer of ...

Join the School of Medicine’s Department of Population and Quantitative Health Sciences to learn about the options available with an MS in clinical research. A webinar will be held Sunday, Dec. 20, at ...

The drug appears effective against both “relapsing” and “primary progressive” forms of the disease, though some analysts ...

Explore the concept of the MS prodrome, a period with subtle symptoms before multiple sclerosis onset. Learn about early ...

MS is the most common demyelinating disease with an estimated prevalence of 3 in 1000 in the United States. It affects approximately 740,000 individuals in the United States and 2.5 million globally.

Dr. Bhargava is an Associate Professor of Neurology at Johns Hopkins University School of Medicine. After obtaining his medical degree from Christian Medical College in Vellore, India, Dr. Bhargava ...

The Combined Bachelor’s/Master’s Degree program (CBM) is intended for highly motivated current CWRU undergraduate students who are candidates for any bachelor's ...